Theranostics in Nuclear Medicine: A New Era in Personalized Cancer Care


“They Treated My Cancer with the Same Tool They Used to Find It.” 

Healthcare International is Transforming Treatment for Cancer Care

Imagine if the same molecule that detected your tumor could also destroy itwithout harming healthy cells around it.

That’s not science fiction. That’s Theranostics—the future of cancer care happening right now at Healthcare International Network.

What Is Theranostics?

Theranostics = Therapy + Diagnostics

It’s a revolutionary branch of nuclear medicine where radioactive molecules are used both to:

  • Detect tumors through scans
  • Treat tumors by delivering targeted radiation

Think of it as a smart missile: It finds the cancer cells, locks onto them, and delivers radiation from within, leaving healthy tissue untouched.

Why Is Theranostics a Game-Changer?

Highly personalized: Matches treatment to tumor type
Minimal side effects: Targets cancer, not the body
Tracks progress in real-time: Imaging and therapy go hand-in-hand
Ideal for hard-to-reach or metastatic cancers

“We’re not just seeing the cancer. We’re treating it at the molecular level.” — Healthcare International

Which Cancers Can Be Treated with Theranostics?

At HCI, we offer theranostic protocols for:

  1. Neuroendocrine Tumors (NETs)
  • Scan: Ga-68 DOTATATE PET-CT
  • Treatment: Lu-177 DOTATATE Therapy
  • High success in pancreatic, GI, or lung NETs
  1. Prostate Cancer
  • Scan: PSMA PET-CT
  • Treatment: Lu-177 PSMA Therapy
  • Especially for metastatic or hormone-resistant prostate cancer
  1. Thyroid Cancer
  • Scan: I-123 or I-131 scan
  • Treatment: Radioiodine Therapy (I-131)
  • Gold standard for differentiated thyroid cancer

How Does It Work?

  1. Diagnostic Scan
    A radiotracer is injected into your bloodstream → attaches to cancer-specific markers → PET/CT imaging shows exactly where the cancer is.
  2. Therapeutic Dose
    The same molecule (tagged with a stronger radioactive isotope) is given in higher dose → delivers targeted radiation to cancer cells → cancer shrinks or stabilizes.
  3. Repeat Imaging
    Post-treatment PET/CT tracks response and guides next steps.

Why International Patients Choose HCI for Theranostics

  • Accredited nuclear medicine center
  • Global access to isotopes (Lutetium-177, Actinium-225, I-131, etc.)
  • Experienced team in theranostic planning & administration
  • Isolation suites with advanced shielding & monitoring
  • Teleconsultation for foreign patients + post-treatment follow-up

Who Refers to Us?

Doctors from UAE, Africa, UK, and South Asia refer patients with:

  • Relapsed prostate or thyroid cancer
  • Inoperable NETs
  • Failed chemo or hormone therapy

Patient Experiences with HCI Network

At HCI, Ms. Dilnoza Rahimova from Uzbekistan found hope after her breast cancer spread despite standard treatments. Through theranostics in nuclear medicine, tiny cancer cells were detected and treated with precision. She shared, ‘For the first time, I feel my treatment is designed just for me

Theranostics isn’t just about treating cancer.
It’s about treating the right cancer, at the right time, in the right patient—without guesswork.

Call, Message or WhatsApp us for appointments.

Healthcare International, your trusted partner for the best medical treatments.


Leave a Reply

Your email address will not be published. Required fields are marked *